Lutz Achtnichts

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

Stéphanie Meier, Eline A.J. Willemse, Sabine Schaedelin et al. · JAMA Neurology · 2023 · 230 citations · Full text

Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis

Alessandro Cagol, Sabine Schaedelin, Muhamed Baraković et al. · JAMA Neurology · 2022 · 156 citations · Full text

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

Raija L.P. Lindberg, Lutz Achtnichts, Francine Hoffmann et al. · Journal of Neuroimmunology · 2008 · 106 citations

Multiple Sclerosis Patients, Autoimmune Disease, Systemic Scleroderma +10

Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis

Ahmed Abdelhak, Pascal Benkert, Sabine Schaedelin et al. · JAMA Neurology · 2023 · 78 citations · Full text

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

Giulio Disanto, Pascal Benkert, Johannes Lorscheider et al. · PLoS ONE · 2016 · 72 citations · Full text